Cameroon vs Europe (WHO region): Hepatitis B surface antigen (HBsAg) prevalence (%)
Cameroon
1.8%
in 2024
Europe (WHO region)
0.1%
in 2024
Cameroon rank
13th
Europe (WHO region) rank
10th
Hepatitis B surface antigen (HBsAg) prevalence (%) over time
- Cameroon
- Europe (WHO region)
How they compare
Cameroon currently reports 1.8% against 0.1% in Europe (WHO region), a difference of 1.7%.
That makes Cameroon's figure about 18.0 times Europe (WHO region)'s.
Across all 10 years both countries report, Cameroon has been ahead every year.
Cameroon ranks 13th and Europe (WHO region) ranks 10th of 194 countries.
Cameroon has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cameroon | Europe (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.0% | 0.1% | 1.9% | Cameroon |
| 2020s | 2.0% | 0.1% | 1.9% | Cameroon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Cameroon or Europe (WHO region)?
- Cameroon, at 1.8% against 0.1% in Europe (WHO region) as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Cameroon and Europe (WHO region)?
- 1.7%, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and Europe (WHO region)?
- 10 years are reported by both, from 2015 to 2024.
- How do Cameroon and Europe (WHO region) rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Cameroon ranks 13th and Europe (WHO region) ranks 10th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.